News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>G Sachs Expects JD HEALTH (06618.HK) 2Q Rev. to Be Stable, Lifts TP to $45.8
Goldman Sachs released a research report expecting JD HEALTH (06618.HK)'s 2Q25 revenue to be stable, meanwhile maintaining stringent expenditure. The broker kept rating at Buy ...
Reset
Send
The window will close in 5 seconds
<Research>G Sachs Expects JD HEALTH (06618.HK) 2Q Rev. to Be Stable, Lifts TP to $45.8
Close
Recommend
11
Positive
12
Negative
2
 
SHORT SELL
 
STOCK INFO

Goldman Sachs released a research report expecting JD HEALTH (06618.HK)  +1.700 (+3.724%)    Short selling $42.09M; Ratio 20.827%   's 2Q25 revenue to be stable, meanwhile maintaining stringent expenditure.

The broker kept rating at Buy for the stock, and lifted its target price from $42.5 to $45.8, corresponding to a 27x PE ratio for 2026 (previously 25x), reflecting JD HEALTH's strong position and revenue visibility in the pharmacy and medical services sectors.

Related NewsM Stanley Raises JD HEALTH (06618.HK) Rev./ Profit Forecasts, Adds TP to $46
Goldman Sachs believed that JD HEALTH is rapidly building pre-position warehouses in first-tier cities such as Guangzhou and Beijing. As of 1H25, JD HEALTH has built approximately 40-50 warehouses nationwide, aiming for about 200 warehouses by the end of 2025, in conjunction with the Group's on-demand delivery plans.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-17 12:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.